Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
PCO patients will be assessed clinically,urine & blood samples will be tested. Systolic &
 diastolic blood pressure, serum glucose & insulin levels, lipid profile, C-reactive protein,
 complete hormonal profile, and Urinary albumin excretion will be measured.
PCO patients with 2 of 3 criteria: oligo- or anovulation ; hyperandrogenism &polycystic
 ovaries. Exclusion criteria: pregnancy, diabetes, hypertension , adrenal & thyroid
 dysfunction.

 Blood samples after overnight fast (8hrs) at day 2 or 3 of menstrual cycle. Serum
 concentration of follicle stimulating hormone (FSH), luteinizing hormone (LH), prolactin,
 total testosterone & sex hormone binding globulin, serum 17-hydroxy (OH) progesterone &
 dehydroepiandrosterone sulfate will be measured.

 Oral glucose tolerance test & plasma insulin levels will be measured. Total cholesterol,
 triglycerides, high& low density lipoproteins. Urinary albumin will be measured& all the data
 will be analysed.
Inclusion Criteria:

 -  PCO patients

 Exclusion Criteria:

 -  pregnancy

 -  diabetes

 -  hypertension

 -  adrenal dysfunction

 -  thyroid dysfunction